You have read all your free articles, to continue reading subscribe to read the rest of this content.
AstraZeneca and Takeda Pharmaceutical have entered an agreement to jointly develop and commercialise MEDI1341, an alpha-synuclein antibody currently in development as a potential treatment for Parkinson’s disease (PD). Alpha-synuclein (α-synuclein) is an aggregation-prone protein that contribuAlready a subscriber Login You have read all your free articles, to continue reading subscribe…
Recipharm has appointed Thomas Beck to a new position, vice president, quality management, effective April 1, 2015. Since 2010 Beck has been head of quality control and assurance - quality manager for Recipharm. He is also president of the pharmaceutical section for quality assurance. Beck’s Already a subscriber Login You…
The company is moving its production of the GAD65 protein, the active substance in its diabetes vaccine Diamyd, from abroad to Umeå, Sweden. The new unit is around 1,000 square meters in size and contains clean rooms, laboratories and offices. Today, the unit has six employees, including proteinAlready a subscriber…
The Uppsala-based company has been named Alumni company at Uppsala Innovation Centre. Sprint Bioscience was accepted to the incubator Uppsala Innovation Centre’s (UIC) program when its product idea and business plan was just in its infancy. Today the company has finished the program at UIC and Already a subscriber Login…
